Nov 13, 2026 · about 600 roles, by press reports
Not linked to AIAstraZeneca cut about 600 jobs in its US respiratory and immunology sales and marketing teams, some of them marketing the asthma drugs Breztri and Airsupra, as part of the three-year programme it announced on 30 October to save about $1.5 billion a year and put the money into its drug pipeline; some of those affected are expected to be moved to other roles. The figure is Bloomberg's, from people familiar with the matter.
What AstraZeneca said (it gave no reason)
"AstraZeneca has cut about 600 jobs from its respiratory and immunology commercial teams in the US as part of its three-year cost-savings initiative, Bloomberg News reported on Friday, citing people familiar with the matter." ... "AstraZeneca declined to comment on the report."Reuters, reporting Bloomberg News (AstraZeneca declined to comment)
No report read mentions AI or tied the cut to AI.
Source: ETHRWorld (Reuters): AstraZeneca cuts 600 sales jobs in US, Bloomberg News reports. Checked Nov 14, 2026.